What antibiotic drops are recommended for treating conjunctivitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antibiotic Eye Drops for Conjunctivitis

For bacterial conjunctivitis, use topical moxifloxacin 0.5% one drop three times daily for 5-7 days as first-line therapy, as it provides superior gram-positive coverage including activity against common pathogens and some MRSA strains. 1, 2

Treatment Algorithm by Etiology

Bacterial Conjunctivitis (Mild to Moderate)

First-Line Options:

  • Moxifloxacin 0.5%: One drop three times daily for 7 days 1, 2
    • Superior gram-positive coverage including S. aureus, S. pneumoniae, H. influenzae, and some MRSA strains 1, 3
    • Microbiological eradication rates of 84-94% 1
    • Also effective against Chlamydia trachomatis 3, 2

Alternative Fluoroquinolones (if moxifloxacin unavailable):

  • Gatifloxacin 0.5%: Day 1 every 2 hours while awake (up to 8 times), then Days 2-7 two to four times daily 1, 4
  • Levofloxacin 0.5%: Demonstrated 89% microbial eradication vs. 80% with ofloxacin 5
  • Ofloxacin 0.3%: Four times daily for 5-7 days (second-line, lower eradication rates) 1, 5

Second-Line Options (when fluoroquinolones unavailable or cost-prohibitive):

  • Gentamicin, tetracycline, or polymyxin B/trimethoprim 1, 6
  • Povidone-iodine 1.25% ophthalmic solution may be as effective as topical antibiotics 6

Severe Bacterial Conjunctivitis

Clinical Features: Copious purulent discharge, pain, marked inflammation 1

Management:

  • Obtain conjunctival cultures and Gram staining BEFORE initiating treatment 1, 6
  • Consider loading dose: One drop every 5-15 minutes, then hourly applications 3
  • Suspect gonococcal or chlamydial infection if severe 1

Gonococcal Conjunctivitis (REQUIRES SYSTEMIC THERAPY)

Critical: Topical antibiotics alone are INSUFFICIENT 1, 6

Treatment:

  • Adults: Ceftriaxone 250 mg IM single dose PLUS azithromycin 1 g oral single dose 1
  • Neonates: Ceftriaxone 25-50 mg/kg IV or IM single dose 1
  • Daily monitoring until resolution is mandatory 1
  • Immediate ophthalmology referral required 1

Chlamydial Conjunctivitis (REQUIRES SYSTEMIC THERAPY)

Critical: Topical therapy alone is insufficient; >50% of infants have infection at other sites 1, 6

Treatment:

  • Adults: Azithromycin 1 g oral single dose OR doxycycline 100 mg oral twice daily for 7 days 1
  • Neonates: Erythromycin base or ethylsuccinate 50 mg/kg/day oral divided into 4 doses for 14 days 1
  • Children ≥45 kg but <8 years: Azithromycin 1 g oral single dose 1
  • Children ≥8 years: Azithromycin 1 g oral single dose OR doxycycline 100 mg oral twice daily for 7 days 1

Viral Conjunctivitis (NO ANTIBIOTICS)

Management:

  • Supportive care ONLY: Refrigerated preservative-free artificial tears four times daily and cold compresses 1
  • Avoid antibiotics - no benefit and promotes resistance 1, 7
  • For HSV conjunctivitis: Topical ganciclovir 0.15% gel OR trifluridine 1% solution PLUS oral antivirals (acyclovir, valacyclovir, or famciclovir) 1
  • Never use topical corticosteroids in HSV without antiviral coverage - potentiates infection 1

Allergic Conjunctivitis (NO ANTIBIOTICS)

Management:

  • Second-generation topical antihistamines with mast-cell stabilizing properties as first-line 1
  • Cold compresses, refrigerated artificial tears, sunglasses 1
  • Avoid antibiotics - no benefit 1

Critical Red Flags Requiring Immediate Ophthalmology Referral

  • Visual loss 1
  • Moderate or severe pain 1
  • Severe purulent discharge 1
  • Corneal involvement (infiltrate, ulcer, opacity) 1
  • Conjunctival scarring 1
  • Lack of response after 3-4 days of appropriate therapy 1, 6
  • History of HSV eye disease 1
  • Immunocompromised state 1
  • Neonatal conjunctivitis (requires systemic treatment) 1

Special Populations

Contact Lens Wearers:

  • Higher risk for Pseudomonas infection - use fluoroquinolones 6
  • Advise discontinuation of contact lens use during treatment 1

Pediatric Patients:

  • Fluoroquinolones (moxifloxacin, levofloxacin, gatifloxacin, ciprofloxacin, besifloxacin) approved for children >12 months 1

Suspected MRSA:

  • Consider compounded topical vancomycin if fluoroquinolones fail 1
  • MRSA isolates generally resistant to fluoroquinolones and aminoglycosides but susceptible to vancomycin 1

Common Pitfalls to Avoid

  • Using antibiotics for viral conjunctivitis - promotes resistance and provides no benefit 1, 7
  • Using topical corticosteroids in HSV without antiviral coverage - potentiates infection 1
  • Treating gonococcal or chlamydial conjunctivitis with topical antibiotics alone - systemic therapy is mandatory 1, 6
  • Failing to consider sexual abuse in children with gonococcal or chlamydial conjunctivitis 1
  • Ignoring local resistance patterns - fluoroquinolone resistance varies geographically 1, 3
  • Not obtaining cultures in severe cases - delays appropriate therapy 1, 6

Infection Control

  • Strict hand hygiene with soap and water 1
  • Avoid close contact for 7-14 days in viral conjunctivitis 1
  • Discard multiple-dose eyedrop containers to avoid cross-contamination 1
  • Separate towels and avoid eye rubbing 6

References

Guideline

Conjunctivitis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment of Bacterial Conjunctivitis with Fluoroquinolone Eye Drops

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment of Bacterial Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.